LEAPS as Stock Replacement

What it is

leaps are options with a year or more to expiration. A deep in-the-money LEAPS call (delta 0.75 to 0.90) behaves much like the stock: it gains roughly 80 to 90 cents for every dollar the stock rises, and it can be bought for a fraction of the share price. Stock replacement means holding that call instead of the shares, freeing the remaining capital for cash, hedges or other positions. The trade-off is that the call carries extrinsic-value that decays to zero at expiration, it pays no dividend, and its maximum loss is the entire premium if the stock is below the strike at expiration.

This is a leverage tool with defined risk, not a free lunch. The leverage is real and it works in both directions.

The logic

A deep in-the-money call is mostly intrinsic-value with a small amount of extrinsic value on top. Buying it is economically similar to buying the stock with borrowed money at an implied interest rate equal to the extrinsic value divided by the strike, plus buying a put at the strike (the "protection" of the defined loss). Whether that is a good deal depends on the implied rate versus your alternatives, and on whether you value the embedded put.

The other side is a market maker who will hedge the call with stock and collect the extrinsic value over time, and, indirectly, anyone selling long-dated calls for income. The market maker is not betting against you; they are charging you a financing and insurance fee. Your edge, if any, is your view on the stock, not the structure.

Setup rules

Market: liquid large caps and index ETFs with LEAPS that have tight markets; check that the bid-ask-spread on the chosen strike is under 2 percent of the option's price.
Timeframe: buy 12 to 24 months out; roll or close when 6 months remain to avoid the steepest decay.
Strike selection: delta 0.75 to 0.90; extrinsic value under 10 percent of the option price. The deeper the strike, the more it behaves like stock and the less time decay you pay.
IV condition: buy when iv-rank is below 40; buying LEAPS in high IV means overpaying for the extrinsic portion.
Capital rule: the number of contracts is set so that the notional stock exposure (contracts times 100 times stock price) equals the stock position you would otherwise have held, not a multiple of it. The freed capital sits in cash or short-term bonds, not in more calls.
Disqualifiers: stocks with large dividends (the call does not receive them and the market prices that in); any name you would not hold as stock through a full cycle.

Entry, stop, target

Enter with a limit order at the mid or slightly worse. The stop is the same as the stop on the underlying thesis: if the stock closes below a predefined level (for example, its 200-day average or the low of the base it broke out from), sell the call. Do not let "it has 14 months left" delay a stop; the delta means you are losing nearly as fast as a stockholder. Target: none in particular; the position is held like stock and rolled forward at 6 months to expiration if the thesis is intact.

Item	Value	Notes
Stock price	200.00	Would have bought 100 shares ($20,000)
LEAPS call	150 strike, 18 months, delta 0.85
Price	58.00 per share ($5,800)	Intrinsic 50.00, extrinsic 8.00
Capital freed	$14,200	Held in cash or treasuries
Implied annual financing cost	About 3.6 percent	8.00 extrinsic over 1.5 years on 150 strike
Thesis stop	Stock closes below 180	Call worth roughly 40, loss about $1,800
Max loss	$5,800	Stock below 150 at expiration

The R:R is the stock's R:R scaled by delta; the structure changes the capital at risk and the financing cost, not the odds.

Position sizing and risk

Size by notional exposure, not by premium. The mistake that ruins LEAPS traders is putting the same dollars into calls that they would have put into stock, which gives 3 to 4 times the exposure. /tools/position-size with the thesis stop on the underlying tells you how many shares' worth of exposure fits your risk budget; buy that many contracts divided by 100. The leverage discussion in /learn/risk-management applies in full.

What breaks it

Time decay. Even deep calls lose their extrinsic value, and it accelerates in the last 6 months. Holding to expiration wastes it; rolling costs a spread each time.
IV drop. Buying in high IV and watching IV fall costs part of the extrinsic value even if the stock is flat.
Dividends. A 3 percent dividend yield is a 3 percent annual drag relative to owning shares; in high-dividend names the "financing cost" is much higher than it looks.
Liquidity. LEAPS markets in many names are wide; a 3 percent spread on entry and exit is 6 percent of the premium gone.
Over-leverage. The defining failure. A trader with $20,000 buys $20,000 of LEAPS (not $5,800) and now has $69,000 of exposure; a 30 percent stock decline is a near-total loss.
Edge decay is not the issue here; the structure has no edge to decay. The risk is that the financing cost quietly exceeds the alternative.

How to test it

Model a LEAPS position against a stock position over 10 years of history on an index ETF, rolling annually, using a pricing model with historical implied volatility. Compare total return, worst drawdown and the cumulative financing cost. Then re-run with the capital freed earning a short-term rate; the comparison tells you whether the embedded financing was cheap or expensive relative to holding shares plus cash. Then simulate the over-leveraged version to see what most people actually do. Paper-trade a single contract through one roll before using real money.

Variations

Poor man's covered call: sell short-dated calls against the LEAPS; see calendar-diagonal-spreads.
LEAPS put for a long-term short thesis; more expensive because of skew.
LEAPS plus trend rule: hold the call only while the underlying is above its 200-day average; see trend-following-200-day.